African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5233

Full Length Research Paper

Inhibition of biofilms on urinary catheters using immobilized Lactobacillus cells

Ifeoma M. Ezeonu*
  • Ifeoma M. Ezeonu*
  • Department of Microbiology, University of Nigeria, Nsukka, Enugu State, Nigeria.
  • Google Scholar
Jennifer U. Kanu
  • Jennifer U. Kanu
  • Department of Microbiology, University of Nigeria, Nsukka, Enugu State, Nigeria.
  • Google Scholar


  •  Received: 15 April 2016
  •  Accepted: 01 June 2016
  •  Published: 07 July 2016

References

Abd-Alkareem AY (2014). Lactobacillus acidophilus as antibiofilm formed by Staphylococcus aureus in vitro. Diyala. J. Med. 7:24-34.

 

Ali OA (2012) Inhibition of uropathogenic Citrobacter adhesion by biosurfactants extracted from vaginal Lactobacillus acidophilus. J. Al-anbar Univers. Med. Sci. 10:11-19.

 

Al-Mathkhury HJF, Ali AS, Ghafil JA (2011). Antagonistic effect of bacteriocin against urinary catheter associated Pseudomonas aeruginosa biofilm. N. Am. J. Med. Sci. 3:367-370.
Crossref

 

Andersen T, Strand BL, Formo K, Alsberg E, Chritensen BE (2012). Alginates as biomaterials in tissue engineering. Carbohydr. Chem. 37:227-258.

 

Barrons R, Tassone D (2008). Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin. Therapeutics 30:453-468.
Crossref

 

Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid I, Pati Y, Chinegwundoh F, Buchholz N. (2008). Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J. Urol. 24:139-144.
Crossref

 

Cheesebrough M (2000). District Laboratory Practice in Tropical Countries. Tropical Health Technology and Butterworth-Heinemann Ltd. Cambridge. 2:63-70.

 

Darouiche RO, Donovan WH, Del Terzo M, Thornby JI, Rudy DC, Hull RA (2001). Pilot trial of bacterial interference for preventing urinary tract infection. Urology 58:339-344.
Crossref

 

Darouiche RO, ThornbyJI, Cerra-Stewart C, Donovan WH, Hull RA (2005). Bacterial interference for prevention of urinary tract infection:A prospective, randomized,placebo-controlled, double blind pilot trial. Clin. Infect. Dis. 41:1531-1534.
Crossref

 

Donlan RM (2001). Biofilms and device-associated infections. Emerg. Infect. Dis. 7:277-280.
Crossref

 

Fracchia L, Cavallo M, Allegrone G, Martinotti MG (2010). A Lactobacillus-derived biosurfactant inhibits biofilm formation of human pathogenic Candida albicans biofilm producers. Curr. Res. Technol. Educ. Top. Appl. Microbiol. Microb. Biotechnol. 2:827-837.

 

Ghanwate NA, Thakare PV, Bhise PR, Dhanke A, Apotikar S (2012). Prevention of biofilm formation in urinary catheter by coating enzymes/gentamycin/EDTA. World Acad. Sci. Eng. Technol. 6:468-470.

 

Hall R, Rudy D, Donovan W, Svanborg C, Wieser I, Stewart C, Darouiche R (2000). Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J. Urol. 163:872-877.
Crossref

 

Maldonado NC, Silva de Ruiz C, Cecilia M, Nader-Macias ME (2007). A simple technique to detect Klebsiella biofilm-forming strains. Inhibitory potential of Lactobacillus fermentum CRL 1058 whole cells and products. Commun. Curr. Res. Educ. Top. Trends Appl. Microbiol. pp. 52-58.

 

Merk K, Borelli C, Korting HC (2005). Lactobacillus-bacteria-host interactions with special regards to the urinary tract. Int. J. Med. Microbiol. 295:9-18.
Crossref

 

Ray K (2011). Infection: Lactobacillus probiotic could prevent recurrent UTI. Nature Rev. Urol. 8:292.
Crossref

 

Reid G, Tieszer C (1994). Use of lactobacilli to reduce the adhesion of Staphylococcus aureus to catheters. Int. Biodeterior. Biodegrad. 34:73-83.
Crossref

 

Reid G, Bruce AW (2002). Probiotics to prevent urinary tract infections: the rationale and evidence. World J. Urol. 24:28-32.
Crossref

 

Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B (2001). Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30:49-52.
Crossref

 

Reid G, Burton J (2002). Use of Lactobacillus to prevent infection by pathogenic bacteria. Microb. Infect. 4:319-324.
Crossref

 

Ruiz FO, Gerbaldo G, Asurmendi P, Pascual LM, Giordano W, Barberis IL (2009). Antimicrobial activity, inhibition of urogenital pathogens and synergistic interactions between Lactobacillus strains. Curr. Microbiol. 59:497-501.
Crossref

 

Saint S, Kaufman SR, Thompson M, Rogers MA, Chenowith CE (2005). A reminder reduces urinary catheterization in hospitalized patients. Joint Commission J. Qual. Patient Safety 31:455-462.

 

Sambanthamoorthy K, Feng X, patel R, Patel S, Paranavitana C (2014). Antimicrobial and antibiofilm potential of biosurfactants isolated from lactobacilli against multi-drug-resistant pathogens. BMC Microbiol. 14:197.
Crossref

 

Stickler DJ (2008). Bacterial biofilms in patients with indwelling urinary catheters. Nature Clin. Practice Urol. 5:598-608.
Crossref

 

Trautner BW, Darouiche RO (2004). Role of biofilm in catheter-associated urinary tract infection. Am. J. Infect. Control 32:177-183.
Crossref

 

Trautner BW, Hull RA, THornby JI, Darouiche RO (2007). Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect. Control Hosp. Epidemiol. 28:92-94.
Crossref

 

Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H (2006). A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int. J. Antimicrob. Agents 28:S30-34.
Crossref

 

Westbroek ML, Davis CL, Fawson LS (2010). Interactions of lactobacilli with pathogenic Streptococcus pyogenes. Infect. Dis. Obstet. Gynecol. pp. 289-743.
Crossref